Citations

Showing 10 of 107930 citations.

Wall Shear Stress Measurement Using Phase Contrast Magnetic Resonance Imaging with Phase Contrast Magnetic Resonance Angiography in Arteriovenous Polytetrafluoroethylene Grafts
Misra, Sanjay , Fu, Alex A., Misra, Khamal D., Glockner, James F., Misra, Sanjay , Mukhopadhyay, Debabrata

Mayo Clinic

Angiology | September 16, 2009 | Volume: 60 | Issue: 4 | Pages: 441-447

10.1177/0003319709335908 | PMID 19625275 Get It

Purpose The purpose of the present article was to determine the changes in luminal vessel area, blood flow, and wall shear stress in both the inflow artery and the venous stenosis of arteriovenous polytetrafluoroethylene (PTFE) grafts. Methods and materials Polytetrafluoroethylene grafts were placed from the carotid artery to the ipsilateral jugular vein in 8 castrated juvenile male pigs. Contrast-enhanced magnetic resonance angiography (MRA) with cine phase-contrast magnetic resonance imaging (MRI) was performed 2 weeks after graft placement. Results The mean wall shear stress at the venous stenosis was 4 times higher than the control vein, while the inflow artery was only 2-fold higher. By day 14, venous stenosis had formed, which was characterized by narrowed area and elevated blood flow. Conclusion By day 14, there is venous stenosis formation in porcine arteriovenous PTFE grafts with increased shear stress with decreased area when compared to control vein.
Cardiovascular Disease Surveillance in the Comparative Effectiveness Landscape
Roger, Véronique L.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | September 15, 2009 | Volume: 2 | Issue: 5 | Pages: 404-406

10.1161/circoutcomes.109.901249 | PMID 20031869 Get It

Sustaining Improvement in Door-to-Balloon Time Over 4 Years
Nestler, David M. , Noheria, Amit , Haro, Luis H., Stead, Latha G., Decker, Wyatt W., Scanlan‐Hanson, Lori N. , Lennon, Ryan J. , Lim, Choon-Chern, Holmes, David R. , Rihal, Charanjit S. , Bell, Malcolm R. , Ting, Henry H. , Ganti, Latha , Stead, Latha G., Rihal, Charanjit S.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | September 15, 2009 | Volume: 2 | Issue: 5 | Pages: 508-513

10.1161/circoutcomes.108.839225 | PMID 20031884 Get It

Background— American College of Cardiology/American Heart Association guidelines recommend a door-to-balloon time (DTB) <90 minutes for nontransferred patients with ST-elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention. Systems of care to achieve and sustain this DTB performance over several years have not been previously reported. Methods and Results— The Mayo Clinic STEMI protocol was implemented in April 2004 and included activation of the cardiac catheterization laboratory by the emergency medicine physician; a single call system to activate the catheterization laboratory; catheterization laboratory staff arrival within 20 to 30 minutes of activation; and real-time performance feedback within 24 to 48 hours. Data were collected on nontransferred STEMI patients. The preimplementation group (June 2002 to March 2004) comprised 96 patients with a median DTB of 97 (interquartile range, 82, 130) minutes, and 40% had a DTB <90 minutes. The postimplementation group (May 2004 to March 2008) comprised 322 patients with a median DTB of 67 (interquartile range, 55, 82) minutes, and 81% had a DTB <90 minutes. Postimplementation DTB was significantly shorter than preimplementation DTB ( P <0.001). In the 4-year follow-up after protocol implementation, the DTB performance remained stable over time ( P =0.41). Conclusions— The Mayo Clinic STEMI protocol implemented strategies to reduce DTB for nontransferred patients with STEMI. DTB was significantly reduced, and the results were sustained over the 4-year follow-up period. Our experience demonstrates the effectiveness and durability of process changes targeting timeliness of primary percutaneous coronary intervention.
Book Reviews
Efron, J.

Mayo Clinic

World Journal of Surgery | September 14, 2009 | Volume: 33 | Issue: 11 | Pages: 2497-2498

10.1007/s00268-009-0199-8 Get It

Serotonergic modulation of basal ganglia circuits
Benarroch, Eduardo E.

Mayo Clinic

Neurology | September 14, 2009 | Volume: 73 | Issue: 11 | Pages: 880-886

10.1212/wnl.0b013e3181b784e7 | PMID 19752456 Get It

Retinal microvascular abnormalities and cognitive decline
Lesage, Suzanne , Wong, Tien Yin , Szklo, Moysés , Catellier, Diane , Cole, Stephen R. , Coker, Laura H., Sharrett, A. Richey, Mosley, Thomas H. , Knopman, David S. , Klein, Ronald , Coresh, Josef , Wong, Tien Y

Mayo Clinic

Neurology | September 14, 2009 | Volume: 73 | Issue: 11 | Pages: 862-868

10.1212/wnl.0b013e3181b78436 | PMID 19752453 Get It

Hand Gangrene Following Unsuccessful Cannulation of the Internal Jugular Vein: A Case Report and Literature Review
Roettges, Paul S., Murray, Peter M. , Hill, David John

Mayo Clinic

HAND | September 14, 2009 | Volume: 5 | Issue: 2 | Pages: 206-209

10.1007/s11552-009-9222-7 | PMID 19756870 Get It

Hand gangrene following vascular cannula placement is uncommon and is usually the result of thrombotic occlusion of an artery. We describe a case of hand gangrene resulting in wrist disarticulation, following multiple unsuccessful attempts at internal jugular vein cannulation in a critically ill patient.
Weight Loss Surgery: Patients Who Regain
Ames, Gretchen E. , Patel, Roshni H., Ames, Steven C. , Lynch, Scott

Mayo Clinic

Obesity and Weight Management | September 14, 2009 | Volume: 5 | Issue: 4 | Pages: 154-161

10.1089/obe.2009.0403 Get It

High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota
Sarafoglou, Kyriakie , Bentler, Kristi, Gaviglio, A., Redlinger‐Grosse, Krista , Anderson, Carolyn S., McCann, Mark, Bloom, Beth Ann, Babovic‐Vuksanovic, Dusica , Gavrilov, Dimitar , Berry, Susan A. , Gaviglio, Amy , Gaviglio, A.

Mayo Clinic

Journal of Inherited Metabolic Disease | September 14, 2009 | Volume: 32 | Issue: S1 | Pages: 169-173

10.1007/s10545-009-1135-7 | PMID 19757147 Get It

SummaryNewborns identified with profound biotinidase deficiency (BTD) by the Minnesota Newborn Screening Program (MN NBS) between 1 October 2004 and 30 May 2008 were all from new immigrant groups. Thirty‐three positive cases of BTD were identified out of 264 727 infants screened by the Wolf colorimetric system during the period of this study by MN NBS. Five cases of profound BTD (0.1 to <0.6 nmol/min per ml) and 26 cases of partial BTD (0.9 to 2.3 nmol/min per ml) were later confirmed through measurement of serum biotinidase activity. The incidence of combined partial and profound BTD of 1/8540 and that of profound BTD of 1/52 945 in Minnesota are unusually high in comparison with the reported worldwide numbers of 1/61 067 for combined BTD and 1/137 401 for profound BTD. Four out of the 5 cases of profound BTD ascertained in the MN NBS cohort were of Somali ethnic background, and the remaining case was of Asian (Pakistani/Indian) ethnic background. All four Somali patients have the P497S mutation, with one of the four being homozygous for the mutation. The three compound heterozygotes all have a novel mutation (P142T) and two of them have another change (Y428Y) that has never been described. Within the last two decades, Minnesota has become home to an estimated 40 000 Somali immigrants and their children (<1% of the total Minnesota population). New population demographics prompt careful analysis of case cohorts to identify specific groups at risk for rare inborn errors of metabolism.
Association of C‐reactive protein with mild cognitive impairment
Roberts, Rosebud O., Geda, Yonas E. , Christianson, Teresa J., Tangalos, Eric G., Ivnik, Robert J., Petersen, Ronald C. , Knopman, David S. , Boeve, Bradley F. , Pankratz, V. Shane , Kullo, Iftikhar J. , Geda, Yonas E

Mayo Clinic

Alzheimer's & Dementia | September 13, 2009 | Volume: 5 | Issue: 5 | Pages: 398-405

10.1016/j.jalz.2009.01.025 | PMID 19751919 Get It

Background Inflammation is proposed to play a role in the development of Alzheimer's disease, and may also be involved in the pathogenesis of mild cognitive impairment (MCI). This study examined the association of inflammatory markers in serum or plasma with prevalent MCI and MCI subtypes in a population‐based sample. Methods Olmsted County, MN, residents aged 70–89 years on October 1, 2004, were evaluated using the Clinical Dementia Rating Scale, a neurological evaluation, and neuropsychological testing. Information ascertained for each participant was reviewed by an expert panel of neuropsychologists, physicians, and nurses, and a diagnosis of normal cognition, MCI, or dementia was made by consensus. C‐reactive protein (CRP), interleukin‐6 (IL‐6), tumor necrosis alpha (TNFα), and adiponectin were measured at baseline. Results Among 313 subjects with MCI and 1570 cognitively normal subjects, a CRP level in the upper quartile (>3.3 mg/L) was significantly associated with MCI (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.00–2.01) and with nonamnestic MCI (OR, 2.05; 95% CI, 1.12–3.78) after adjusting for age, sex, and years of education. However, there was no association with amnestic MCI (OR, 1.21; 95% CI, 0.81–1.82). No association was observed with the other inflammatory markers. Conclusions Plasma CRP is associated with prevalent MCI and with nonamnestic MCI in elderly, nondemented persons in a population‐based setting. These findings suggest the involvement of inflammation in the pathogenesis of MCI.